The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer’s disease
Open accessAbstract
Alzheimer's disease (AD) is characterized by beta-amyloid accumulation, phosphorylated tau formation, hyperactivation of glial cells, and neuronal loss. The mechanisms of AD pathogenesis, however, remain poorly understood, partially due to the lack of relevant models that can comprehensively recapitulate multistage intercellular interactions in human AD brains. Here we present a new three-dimensional (3D) human AD triculture model using neurons, astrocytes, and microglia in a 3D microfluidic platform. Our model provided key representative AD features: beta-amyloid aggregation, phosphorylated tau accumulation, and neuroinflammatory activity. In particular, the model mirrored microglial recruitment, neurotoxic activities such as axonal cleavage, and NO release damaging AD neurons and astrocytes. Our model will serve to facilitate the development of more precise human brain models for basic mechanistic studies in neural-glial interactions and drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Improved models of AD are underway. These include the use of primates [276], brain organoids [249] and further transgenic mouse lines.”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [249]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This tri-culture system, consisting of human stem cell-derived neurons, astrocytes and microglia cultured within 3D Matrigel, was used to study the migration and phagocytosis of microglia as well as microglia-induced neurite degeneration and cell death in an AD brain-like environment.”
From Acoustofluidic assembly of 3D neurospheroids to model Alzheimer's disease (2020) · cites this paper as [23]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several studies have demonstrated that astrocytes are capable of stimulating microglia phagocytosis by secretion of cytokines such as IL33 and the complement protein C3 [19, 34].”
From Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates (2021) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The model showed Aβ aggregation, p-tau accumulation, and secretion of inflammatory cytokines can be used to study the pathogenesis of AD.”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [140]
The cited source says what the claim attributes to it.
In the citing paper
“Other than the neurotoxicity of Aβ aggregates, the AD brain contains more complex pathology, which is highly related to neuroinflammation.23, 43”
From Acoustofluidic assembly of 3D neurospheroids to model Alzheimer's disease (2020) · cites this paper as [23]
The cited source says what the claim attributes to it.
In the citing paper
“Recently, by integrating the microfluidics and 3D Matrigel matrix, a tri-culture model was established to recapitulate the key features of AD neuroinflammatory processes.23”
From Acoustofluidic assembly of 3D neurospheroids to model Alzheimer's disease (2020) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Self-citationThe P2Y12 receptor regulates microglial activation by extracellular nucleotides
Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W.-B., & Julius, D. (2006) · Nature Neuroscience · doi:10.1038/nn1805 · Cited by 1,542
Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253
A three-dimensional human neural cell culture model of Alzheimer’s disease
Choi, S. H., Kim, Y. H., Hebisch, M., Sliwinski, C., Lee, S., D’Avanzo, C., Chen, H., Hooli, B., Asselin, C., Muffat, J., et al. (2014) · Nature · doi:10.1038/nature13800 · Cited by 1,195
Self-citationAlzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
Griciuc, A., Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. H., Hyman, B. T., & Tanzi, R. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.014 · Cited by 1,004
Self-citation
Cited by
Sorted by citations
Items 301–400 of 650
Amini, J., Sanchooli, N., Milajerdi, M.-H., Baeeri, M., Haddadi, M., & Sanadgol, N. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2023.2210409 · Cited by 19
Ulaganathan, S., & Pitchaimani, A. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121918 · Cited by 23
Solana‐Manrique, C., Sánchez‐Pérez, A. M., Paricio, N., & Muñoz‐Descalzo, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020620 · Cited by 21
Gopalakrishnan, M., Kannan, D., Elumalai, K., Karunakar, K. K., Jayaraj, S., Devaraji, M., & Jayaprakash, N. (2025) · Biomedical Technology · doi:10.1016/j.bmt.2025.100089 · Cited by 18
Rozenblum, G., Ait‐Aissa, K., Zahran, G. E. D., Alipour, M., Sahyoun, A. M., Munkhsaikhan, U., Kassan, A., Ishrat, T., Wang, Q., Abidi, A. H., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.71011 · Cited by 19
Buentello, D. C., García-Corral, M., Santiago, G. T., & Álvarez, M. M. (2022) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2022.3217486 · Cited by 19
Park, H. J., Kim, J., & Ryou, C. (2023) · Cell Proliferation · doi:10.1111/cpr.13399 · Cited by 18
A 3D human co-culture to model neuron-astrocyte interactions in tauopathies
Batenburg, K. L., Sestito, C., Cornelissen‐Steijger, P., van Weering, J. R. T., Price, L., Heine, V. M., & Scheper, W. (2023) · Biological Procedures Online · doi:10.1186/s12575-023-00194-2 · Cited by 22
Abdulla, A., Chen, S., Chen, Z., Wang, Y., Yan, H., Chen, R., Ahmad, K. Z., Liu, K., Yan, C., He, J., et al. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115635 · Cited by 21
Supakul, S., Murakami, R., Oyama, C., Shindo, T., Hatakeyama, Y., Itsuno, M., Bannai, H., Shibata, S., Maeda, S., & Okano, H. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-023-00310-5 · Cited by 20
Bali, P., Banik, A., Nehru, B., & Anand, A. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01680-z · Cited by 18
Microphysiological Systems for Neurodegenerative Diseases in Central Nervous System
Bae, M., Yi, H., Jang, J., & Cho, D. (2020) · Micromachines · doi:10.3390/mi11090855 · Cited by 19
Advances in Genetic and Molecular Understanding of Alzheimer’s Disease
Ibáñez, L., Cruchaga, C., & Fernández, M. V. (2021) · Genes · doi:10.3390/genes12081247 · Cited by 20
Alzheimer’s Disease: Current Perspectives and Advances in Physiological Modeling
Boder, E. J., & Banerjee, I. A. (2021) · Bioengineering · doi:10.3390/bioengineering8120211 · Cited by 18
Modeling Alzheimer’s disease brains in vitro
Henstridge, C. M., & Spires‐Jones, T. L. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0177-2 · Cited by 19
Sohn, E., Kim, Y. J., Kim, J., & Jeong, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.607403 · Cited by 18
Struzyna, L. A., & Watt, M. L. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.120.000142 · Cited by 20
Cell models for Down syndrome-Alzheimer’s disease research
Wu, Y., West, N. R., Bhattacharyya, A., & Wiseman, F. K. (2022) · Neuronal Signaling · doi:10.1042/ns20210054 · Cited by 17
Modelling Alzheimer's disease using human brain organoids: current progress and challenges
Yanakiev, M., Soper, O., Berg, D. A., & Kang, E. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.40 · Cited by 17
Tackling neurodegeneration in vitro with omics: a path towards new targets and drugs
Carraro, C., Montgomery, J. V., Klimmt, J., Paquet, D., Schultze, J. L., & Beyer, M. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1414886 · Cited by 16
Wheeler, H. B., Madrigal, A. A., & Chaim, I. A. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317860121 · Cited by 18
Neuroimmune interactions in Alzheimer's disease—New frontier with old challenges?
Prokop, S., Lee, V. M. ‐., & Trojanowski, J. Q. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.10.002 · Cited by 17
Using human pluripotent stem cell models to study autism in the era of big data
Nehme, R., & Barrett, L. E. (2020) · Molecular Autism · doi:10.1186/s13229-020-00322-9 · Cited by 17
Porterfield, V. M., Khan, S. S., Foff, E. P., Köseoğlu, M. M., Blanco, I. K., Jayaraman, S., Lien, E. L., McConnell, M. J., Bloom, G. S., Lazo, J. S., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.02.011 · Cited by 18
Brain organoid model systems of neurodegenerative diseases: recent progress and future prospects
Shaikh, S., Siddique, L., Khalifey, H. T., Mahereen, R., Raziq, T., Firdous, R. M., Siddique, A., Shakir, I. M., Ahmed, Z., Akbar, A., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1604435 · Cited by 18
Bhargava, A., Sandoval-Castellanos, A. M., Shah, S. S., & Ning, K. (2022) · Interface Focus · doi:10.1098/rsfs.2022.0040 · Cited by 15
Zhang, X., Xie, G., Ma, H., Ding, S., Wu, Y., Fei, Y., Cheng, Q., Huang, Y., & Wang, Y. (2023) · Biofabrication · doi:10.1088/1758-5090/acee21 · Cited by 19
The Evolution of Technology‐Driven In Vitro Models for Neurodegenerative Diseases
Vitis, E. D., Stanzione, A., Romano, A., Quattrini, A., Gigli, G., Moroni, L., Gervaso, F., & Polini, A. (2024) · Advanced Science · doi:10.1002/advs.202304989 · Cited by 16
Application of advanced biosensors in nervous system diseases
Meng, Z., Zhang, Y., Lu, Y., Yuan, F., Wang, J., Chen, J., Liu, J., Wang, G., & Zang, G. (2024) · Interdisciplinary medicine · doi:10.1002/inmd.20240024 · Cited by 17
Building a Human Brain for Research
Bitar, M., & Barry, G. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00022 · Cited by 17
Vignon, A., Salvador-Prince, L., Lehmann, S., Perrier, V., & Torrent, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168769 · Cited by 17
Grekhnev, D. A., Kaznacheyeva, E. V., & Vigont, V. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020624 · Cited by 16
Experimental models to study prion disease pathogenesis and identify potential therapeutic compounds
Vorberg, I. M., & Chiesa, R. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.02.002 · Cited by 16
Advanced Biomanufacturing Technologies for Micro-physiological Systems
Kim, M. K., Yoon, J., Kim, D., Kim, J., Kim, J.-S., Go, G., Song, J., Son, S., Park, K., Lee, D., et al. (2025) · International Journal of Precision Engineering and Manufacturing · doi:10.1007/s12541-025-01330-6 · Cited by 16
Self-citationVarshavskaya, K. B., Mitkevich, V. A., Makarov, A. А., & Barykin, E. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315036 · Cited by 18
Thermodynamic and kinetic approaches for drug discovery to target protein misfolding and aggregation
Vendruscolo, M. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2221024 · Cited by 15
Models and approaches to comprehend and address glial inflammation following spinal cord injury
Patil, V., Bohara, R. A., Kanala, V. K., McMahon, S. S., & Pandit, A. S. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103722 · Cited by 16
Spitz, S., Schobesberger, S., Brandauer, K., & Ertl, P. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10604 · Cited by 17
Environmental aluminum oxide inducing neurodegeneration in human neurovascular unit with immunity
Xue, Y., Tran, M., Diep, Y. N., Shin, S., Lee, J., Cho, H., & Kang, Y. J. (2024) · Scientific Reports · doi:10.1038/s41598-024-51206-4 · Cited by 15
Self-citationZwi‐Dantsis, L., Jayarajan, V., Church, G. M., Kamm, R. D., de Magalhães, J. P., & Moeendarbary, E. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500217 · Cited by 16
Neurodegeneration in a dish: advancing human stem-cell-based models of Alzheimer’s disease
Klimmt, J., Dannert, A., & Paquet, D. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.01.008 · Cited by 16
Biomaterials for on-chip organ systems
Hassan, S., Heinrich, M. A., Çeçen, B., Prakash, J., & Zhang, Y. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102906-0.00019-2 · Cited by 18
Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease
Coccia, E., & Ahfeldt, T. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02326-5 · Cited by 16
Reprogramming iPSCs to study age-related diseases: Models, therapeutics, and clinical trials
Esteves, F., Brito, D. V. C., Rajado, A. T., Silva, N., Apolónio, J. D., Roberto, V. P., Araújo, I. M., Nóbrega, C., Castelo‐Branco, P., Bragança, J., et al. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111854 · Cited by 17
Role of induced pluripotent stem cells in lysosomal storage diseases
Kido, J., Nakamura, K., & Era, T. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103540 · Cited by 16
Rubio, A. D., Hamilton, L. L., Bausch, M., Jin, M., Papetti, A. V., Jiang, P., & Yelamanchili, S. V. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10181-x · Cited by 17
Neuroinflammation and nutrition in Alzheimer’s disease
Park, H., Ni, M., & Le, Y. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1622571 · Cited by 17
Central nervous system organoids for modeling neurodegenerative diseases
Hou, P., & Kuo, H. (2022) · IUBMB Life · doi:10.1002/iub.2595 · Cited by 14
Madl, C. M. (2023) · iScience · doi:10.1016/j.isci.2023.106825 · Cited by 16
Brain organoid methodologies to explore mechanisms of disease in progressive multiple sclerosis
Simões-Abade, M. B. C., Patterer, M., Nicaise, A. M., & Pluchino, S. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1488691 · Cited by 14
Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models
Correia, C. D., Calado, S. M., Matos, A., Esteves, F., Sousa‐Coelho, A. L. D., Campinho, M. A., & Fernandes, M. T. (2025) · Cells · doi:10.3390/cells14040292 · Cited by 16
Shao, X., Wang, C., Wang, C., Han, L., Han, Y., Nižetić, D., Zhang, Y., & Han, L. G. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100698 · Cited by 14
Lazar, S. V., Mor, S., Wang, D., Goldbloom‐Helzner, L., Clark, K. C., Hao, D., Farmer, D. L., & Wang, A. (2021) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1541 · Cited by 14
Huang, B., Peng, J., Huang, X., Liang, F., Wang, L., Shi, J., Yamada, A., & Chen, Y. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c18465 · Cited by 14
Hameed, S. S., Swain, S., Jana, S., Chhablani, J. K., Ali, M. J., Pappuru, R. R., Tyagi, M., Vishwakarma, S., Sailaja, N., Chakrabarti, S., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01445 · Cited by 14
Discovery of new epigenomics-based biomarkers and the early diagnosis of neurodegenerative diseases
Lee, D., Choi, Y. H., Seo, J., Kim, J. K., & Lee, S. B. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101069 · Cited by 14
Nand, S., Chaturvedi, V. K., Singh, S. P., & Singh, M. P. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00219 · Cited by 14
Wendt, S., Lin, A. J., Ebert, S. N., Brennan, D. J., Cai, W., Bai, Y., Kong, D. Y., Sorrentino, S., Groten, C. J., Lee, C., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03433-3 · Cited by 13
Ferrari, I., Limiti, E., Giannitelli, S. M., Trombetta, M., Rainer, A., D’Amelio, M., Barbera, L. L., & Gori, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199478 · Cited by 15
μF-hBBB Chip Together with Tetrahedral DNA Frameworks for Visualization of LPS-Mediated Inflammation
Xu, Y., Li, S., Wang, C., Xie, X., & Mi, X. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c01804 · Cited by 13
Decoding microglial functions in Alzheimer’s disease: insights from human models
Rao, C., Semrau, S., & Fossati, V. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.02.011 · Cited by 14
Timofeeva, A. M., Aulova, K. S., & Nevinsky, G. A. (2025) · Brain Sciences · doi:10.3390/brainsci15050486 · Cited by 17
Miao, Y., Wang, N., Shao, W., Xu, Z., Yang, Z., Wang, L., Ju, C., Zhang, R., & Zhang, F. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09861-2 · Cited by 14
Snow, A. D., Cummings, J. A., Tanzi, R. E., & Lake, T. P. (2021) · Scientific Reports · doi:10.1038/s41598-020-79275-1 · Cited by 14
Self-citationModeling Ischemia-Reperfusion Injury in Stroke Using the BBB Chip
Wu, Y., Zhang, M., Wang, P., Liu, H., Zhang, X., & Qin, J. (2025) · ACS Omega · doi:10.1021/acsomega.5c06071 · Cited by 14
Microfluidic Manipulation for Biomedical Applications in the Central and Peripheral Nervous Systems
Li, Z., Jiang, Z., Lu, L., & Liu, Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010210 · Cited by 12
Cuní‐López, C., Stewart, R., White, A. R., & Quek, H. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578017 · Cited by 9
Traldi, C., Chiappini, V., Menduti, G., Tonda‐Turo, C., & Boido, M. (2023) · Frontiers in Medical Engineering · doi:10.3389/fmede.2023.1270943 · Cited by 12
Human brain organoids in Alzheimer’s disease
Kang, Y. J., & Cho, H. (2021) · Organoid · doi:10.51335/organoid.2021.1.e5 · Cited by 13
Self-citationMicrofluidic Techniques for Next‐Generation Organoid Systems
Gong, J., Li, M., Kang, J., Yin, Z., Cha, Z., Yang, J., & Xu, H. (2022) · Advanced Materials Interfaces · doi:10.1002/admi.202200846 · Cited by 12
Balez, R., Stevens, C. H., Lenk, K., Maksour, S., Sidhu, K., Sutherland, G. T., & Ooi, L. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0395 · Cited by 13
Jahagirdar, D., Bangde, P. S., Jain, R. D., & Dandekar, P. P. (2021) · Biotechnology Journal · doi:10.1002/biot.202100154 · Cited by 13
Huang, Z. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221042 · Cited by 12
Yoon, D., & Nam, Y. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116507 · Cited by 13
Hydrogen Peroxide-Releasing Hydrogel-Mediated Cellular Senescence Model for Aging Research
Wei, S., Thi, P. L., Zhang, Y., Park, M.-Y., Do, K.-H., Thi, T. T. H., Morgan, N., Dao, T., Heo, J., Jo, Y., et al. (2025) · Biomaterials Research · doi:10.34133/bmr.0161 · Cited by 11
Self-citationHuman mini-brains for reconstituting central nervous system disorders
Kang, Y. J., Xue, Y., Shin, J. H., & Cho, H. (2023) · Lab on a Chip · doi:10.1039/d2lc00897a · Cited by 11
Self-citationMaksour, S., & Ooi, L. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15885 · Cited by 12
Chen, C., Liu, Y., Lu, C.-H., Lee, P., Tsai, Y.-C., Wu, J.-S., Chen, P., & Chen, B. (2019) · Micromachines · doi:10.3390/mi10090599 · Cited by 11
Böröczky, C., Paszternák, A., Laufer, R., Tarnóczi, K., Sikur, N., Bagaméry, F., Szökő, É., Varga, K., & Tábi, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146581 · Cited by 11
Zheng, Y., Zhou, W., Chang, H., & Zheng, K. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1764964 · Cited by 12
Jeong, S., Kang, H. W., Kim, S. H., Hong, G., Nam, M., Seong, J., Yoon, E.-S., Cho, I., Chung, S. H., Bang, S., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf0925 · Cited by 10
Approaches for studying neuroimmune interactions in Alzheimer’s disease
Lin, C., Tian, Y., Tanzi, R. E., & Jorfi, M. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.10.002 · Cited by 11
Self-citationTakeuchi, L. E., Kalia, L. V., & Simmons, C. A. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106864 · Cited by 11
Hasan, M. F., & Trushina, E. V. (2022) · Brain Sciences · doi:10.3390/brainsci12050552 · Cited by 10
Botulinum Neurotoxin Induces Neurotoxic Microglia Mediated by Exogenous Inflammatory Responses
Ambrin, G., Kang, Y. J., Do, K., Lee, C., Singh, B. R., & Cho, H. (2024) · Advanced Science · doi:10.1002/advs.202305326 · Cited by 11
Self-citationTissue engineering to better understand senescence: Organotypics come of age
Milligan, D., Tyler, E. J., & Bishop, C. L. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111261 · Cited by 10
3D In Vitro Human Organ Mimicry Devices for Drug Discovery, Development, and Assessment
Rodríguez‐García, A., Oliva, J., Flores, C., & Hosseini, S. (2020) · Advances in Polymer Technology · doi:10.1155/2020/6187048 · Cited by 10
Activity-dependent release of phosphorylated human tau from Drosophila neurons in primary culture
Ismael, S., Sindi, G., Colvin, R. A., & Lee, D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101108 · Cited by 12
Langlie, J. A., Mittal, R., Finberg, A., Bencie, N. B., Mittal, J., Omidian, H., Omidi, Y., & Eshraghi, A. A. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335836 · Cited by 10
Tian, C., Ao, Z., Cerneckis, J., Cai, H., Chen, L., Niu, H., Takayama, K., Kim, J., Shi, Y., Gu, M., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu2708 · Cited by 9
Inhibition of insulin-degrading enzyme in human neurons promotes amyloid-β deposition
Rowland, H. A., Moxon, S. R., Corbett, N. J., Hanson, K., Fisher, K., Kellett, K. A. B., & Hooper, N. M. (2023) · Neuronal Signaling · doi:10.1042/ns20230016 · Cited by 15
Ferritin nanocage-enabled detection of pathological tau in living human retinal cells
Barolo, L., Gigante, Y., Mautone, L., Ghirga, S., Soloperto, A., Giorgi, A., Ghirga, F., Pitea, M., Incocciati, A., Mura, F., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-62188-8 · Cited by 10
A longevity‐specific bank of induced pluripotent stem cells from centenarians and their offspring
Dowrey, T. W., Cranston, S. F., Skvir, N. J., Lok, Y., Gould, B., Petrowitz, B., Villar, D., Shan, J., James, M. F., Dodge, M., et al. (2024) · Aging Cell · doi:10.1111/acel.14351 · Cited by 10
Kim, H., Le, B., Goshi, N., Zhu, K., Grodzki, A. C., Lein, P. J., Zhao, M., & Şeker, E. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241291142 · Cited by 11
Advancing organ-on-chip systems: the role of microfluidics in neuro-cardiac research
Ferreira, M. J., Colombani, S., Bernardin, A. A., Lacampagne, A., Pasquié, J., Costa, P. F., Charlot, B., & Méli, A. C. (2025) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2025.100227 · Cited by 9
Adak, S., Singh, S., Jain, R., Tiwari, A., Singh, B., Kumar, S., Dadhwal, A., Chakroborty, A., Sharma, A. K., Singh, R. P., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1646551 · Cited by 12
Kiris, E. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_683 · Cited by 9
Building in vitro models of the brain to understand the role ofAPOEin Alzheimer’s disease
Pinals, R. L., & Tsai, L. (2022) · Life Science Alliance · doi:10.26508/lsa.202201542 · Cited by 10
Functional bioengineered tissue models of neurodegenerative diseases
Mullis, A. S., & Kaplan, D. L. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122143 · Cited by 10
Organ mimicking technologies and their applications in drug discovery
Qu, Y., Ye, J., Lin, B., Luo, Y., & Zhang, X. (2023) · Intelligent Pharmacy · doi:10.1016/j.ipha.2023.05.003 · Cited by 11
Metadata
- Authors
- Park, J., Wetzel, I., Marriott, I., Dréau, D., D’Avanzo, C., Kim, D. Y., Tanzi, R. E., & Cho, H.
- Affiliations
- University of North Carolina at Charlotte (US)
- Harvard University (US)
- Corresponding author
- Cho, Hansang
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2018-06-27
- Volume
- 21
- Issue
- 7
- Pages
- 941-951
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC6800152
- OpenAlex
- W2809913775
- Cited by
- 644
- References
- 48
- Citations by year
- 2026: 35 · 2025: 78 · 2024: 90 · 2023: 91 · 2022: 78 · 2021: 110 · 2020: 92 · 2019: 58 · 2018: 12
- FWCI
- 46.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (P01AG015379, R01AG061891, RF1AG048080, R01AG014713)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, microfluidic platform, neuroinflammation, amyloid-beta aggregation, phosphorylated tau, microglial recruitment, human brain model
- MeSH terms
- Alzheimer Disease, Astrocytes, Humans, Inflammation, Nerve Degeneration, Neurons, Phosphorylation, Amyloid beta-Peptides, tau Proteins, Microglia, Cell Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
